| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.57 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |